Implantable therapeutic substance delivery device having a piston pump with an anti-cavitation valve

• US 7,201,746 B2
• Filed: 09/14/2001
• Issued: 04/10/2007
• Est. Priority Date: 04/10/2001
• Status: Expired due to Term

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Olsen, James M.
• Primary Examiner(s): Lucchesi; Nicholas D.
• Assistant Examiner(s): DESANTO, MATTHEW F
• Application Number:
  US09/952,870
• Publication Number:
  US 20020173772A1
• Time in Patent Office: 2,034 Days
• Field of Search: 604/151, 604/152, 604/246, 604/247, 604/891.1, 604/288.01, 604/288.03, 604/288.04
• US Class Current: 604/891.1
• CPC Class Codes: A61M 39/24 Check- or non-return valves
• CPC Class Codes: A61M 5/14216 Reciprocating piston type
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: F04B 17/046 the fluid flowing through the moving part of the motor
• CPC Class Codes: F04B 53/1062 fixed at two or more points at its periphery

Abstract

A medical device known as an implantable therapeutic substance infusion device is configured for implanting in humans to deliver a therapeutic substance such as pharmaceutical compositions, genetic materials, and biologics to treat a variety of medical conditions such as pain, spastisity, cancer, and many other conditions. The therapeutic substance infusion device has a piston pump with an anti-cavitation valve to reduce gas formation, increase accuracy, improve efficiency and has many other improvements. The therapeutic substance infusion device has a housing, a therapeutic substance reservoir, a power source carried in the housing, electronics, a piston pump, an inlet valve, and anti-cavitation valve. The piston pump is configured for pumping therapeutic substance from the therapeutic substance reservoir through an infusion port at a programmed rate. The anti-cavitation is in fluid communication with a reservoir outlet and an inlet chamber to substantially preventing retrograde flow of therapeutic substance from the inlet chamber back through the reservoir outlet. Many embodiments of the anti-cavitation valve and its methods of operation are possible.

Claims

1. An implantable therapeutic substance delivery device comprising:

a housing;

a therapeutic substance reservoir carried in the housing, the therapeutic substance reservoir having a reservoir outlet;

a power source carried in the housing;

electronics coupled to the power source; and

,

a piston pump coupled to the electronics and coupled to the reservoir outlet, the piston pump comprising a pump cylinder in which a pump piston moves and an inlet chamber in fluid communication with a pumping chamber through a fluid path in the pump cylinder, wherein the piston pump is configured for pumping therapeutic substance from the therapeutic substance reservoir through an infusion port at a programmed rate;

an inlet valve in fluid communication with the reservoir, the inlet valve configured for controlling therapeutic substance flow from the inlet chamber into the pumping chamber; and

an anti-cavitation valve in fluid communication with the reservoir outlet and the inlet chamber, the anti-cavitation substantially preventing retrograde flow of therapeutic substance from the inlet chamber back toward the reservoir outlet.

2. The implantable therapeutic substance delivery device as in claim 1 wherein the anti-cavitation valve substantially prevents pumping chamber pressure from decreasing below a predetermined low pumping chamber pressure during pump piston retraction.

3. The implantable therapeutic substance delivery device as in claim 1 wherein the anti-cavitation valve causes a pumping chanter to fill more completely when the pump piston is retracted.

4. The implantable therapeutic substance delivery device as in claim 1 wherein the anti-cavitation valve improves piston pump efficiency by infusing substantially all the therapeutic substance that enters the inlet chamber.

5. The implantable therapeutic substance delivery device as in claim 1 wherein the anti-cavitation valve is carried on an inlet enclosure that is in fluid communication with the inlet chamber.

6. The implantable therapeutic substance delivery device as in claim 1 wherein the anti-cavitation valve is carried in the therapeutic substance inlet that is in fluid communication with the inlet chamber.

7. An implantable therapeutic substance delivery device comprising:

at least one housing;

a therapeutic substance reservoir carried in one of the at least one housing, the therapeutic substance reservoir having a reservoir outlet;

a power source carried in one of the at least one housing;

electronics coupled to the power source;

a piston pump coupled to the electronics and coupled to the reservoir outlet, the piston pump comprising a pump cylinder in which a pump piston moves and an inlet chamber in fluid communication with a pumping chamber through a fluid path in the pump cylinder, wherein the piston pump is configured for pumping therapeutic substance from the therapeutic substance reservoir through an infusion port at a programmed rate;

an inlet valve in fluid communication with the reservoir, the inlet valve configured for controlling therapeutic substance flow from the inlet chamber into the pumping chamber; and

an anti-cavitation valve in fluid communication with the reservoir outlet and the inlet chamber, the anti-cavitation substantially preventing retrograde flow of therapeutic substance from the inlet chamber back toward the reservoir outlet.

8. The implantable therapeutic substance delivery device as in claim 7 wherein the anti-cavitation valve is carried on an inlet enclosure that is in fluid communication with the inlet chamber.

9. The implantable therapeutic substance delivery device as in claim 7 wherein the anti-cavitation valve is carded in the therapeutic substance inlet that is in fluid communication with the inlet chamber.

10. An implantable therapeutic substance delivery device comprising:

at least one housing;

a therapeutic substance reservoir carried in one of the at least one housing, the therapeutic substance reservoir having a reservoir outlet;

a power source carried in one of the at least one housing;

electronics coupled to the power source;

means for pumping coupled to the electronics and coupled to the reservoir outlet, the means for pumping configured to pump a therapeutic substance from the therapeutic substance reservoir through an infusion outlet at a programmed rate;

means for inlet valuing configured to control the flow of therapeutic substance from the reservoir outlet into a pumping chamber; and

means for anti-cavitation valuing configured to substantially prevent retrograde flow of therapeutic substance from the inlet chamber back toward the reservoir outlet.

11. The implantable therapeutic substance delivery device as in claim 10 wherein the at least one housing comprises one housing.

12. The implantable therapeutic substance delivery device as in claim 10 wherein the means for anti-cavitation valving is carried on an inlet enclosure that is in fluid communication with the inlet chamber.

13. The implantable therapeutic substance delivery device as in claim 10 wherein the means for anti-cavitation valving is carried in the therapeutic substance inlet that is in fluid communication with the inlet chamber.

14. An implantable therapeutic substance delivery device comprising:

a housing;

a therapeutic substance reservoir carried in the housing, the therapeutic substance reservoir having a reservoir outlet;

a power source carried in the housing;

electronics coupled to the power source; and

,

a piston pump coupled to the electronics and coupled to the reservoir outlet, the piston pump comprising a pump cylinder in which a pump piston moves and an inlet chamber in fluid communication with a pumping chamber through a fluid path in the pump cylinder, wherein the piston pump is configured for pumping therapeutic substance from the therapeutic substance reservoir through an infusion port at a programmed rate;

an inlet valve in fluid communication with the reservoir, the inlet valve configured for controlling therapeutic substance flow from the inlet chamber into the pumping chamber; and

an anti-cavitation valve in fluid communication with the reservoir outlet and the inlet chamber, the anti-cavitation substantially preventing retrograde flow of therapeutic substance from the inlet chamber back toward the reservoir outlet;

wherein the anti-cavitation valve substantially prevents pumping chamber pressure from decreasing below a predetermined low pumping chamber pressure during pump piston retraction such that the therapeutic substance contained in the pumping chamber at the predetermined low pumping chamber pressure retains dissolved gasses in the therapeutic substance.

15. The implantable therapeutic substance delivery device as in claim 14 wherein the anti-cavitation valve causes a pumping chamber to fill more completely when the pump piston is retracted.

16. The implantable therapeutic substance delivery device as in claim 14 wherein the anti-cavitation valve improves piston pump efficiency by infusing substantially all the therapeutic substance that enters the inlet chamber.

17. The implantable therapeutic substance delivery device as in claim 14 wherein the anti-cavitation valve is carried on an inlet enclosure that is in fluid communication with the inlet chamber.

18. The implantable therapeutic substance delivery device as in claim 14 wherein the anti-cavitation valve is carried in the reservoir outlet that is in fluid communication with the inlet chamber.

19. The implantable therapeutic substance delivery device as in claim 14 further comprising an outlet valve configured to control the flow of therapeutic substance from the pumping chamber into the infusion port.

20. An implantable therapeutic substance delivery device comprising:

a housing;

a therapeutic substance reservoir carried in the housing, the therapeutic substance reservoir having a reservoir outlet;

a power source carried in the housing;

electronics coupled to the power source; and

,

a piston pump coupled to the electronics and coupled to the reservoir outlet, the piston pump comprising a pump cylinder in which a pump piston moves and an inlet chamber in fluid communication with a pumping chamber through a fluid path in the pump cylinder, wherein the piston pump is configured for pumping therapeutic substance from the therapeutic substance reservoir through an infusion port at a programmed rate;

an inlet valve in fluid communication with the reservoir, the inlet valve configured for controlling therapeutic substance flow from the inlet chamber into the pumping chamber; and

an anti-cavitation valve in fluid communication with the reservoir outlet and the inlet chamber, the anti-cavitation substantially preventing retrograde flow of therapeutic substance from the inlet chamber back toward the reservoir outlet;

wherein the anti-cavitation valve substantially prevents pumping chamber pressure from decreasing below a predetermined low pumping chamber pressure during pump piston retraction and wherein the anti-cavitation valve increases piston pump delivery accuracy by substantially preventing the formation of gas bubbles in the pumping chamber.

21. The implantable therapeutic substance delivery device as in claim 20 wherein the anti-cavitation valve causes a pumping chamber to fill more completely when the pump piston is retracted.

22. The implantable therapeutic substance delivery device as in claim 20 wherein the anti-cavitation valve improves piston pump efficiency by infusing substantially all the therapeutic substance that enters the inlet chamber.

23. The implantable therapeutic substance delivery device as in claim 20 wherein the anti-cavitation valve is carried on an inlet enclosure that is in fluid communication with the inlet chamber.

24. The implantable therapeutic substance delivery device as in claim 20 wherein the anti-cavitation valve is carried in the reservoir outlet that is in fluid communication with the inlet chamber.

25. The implantable therapeutic substance delivery device as in claim 20 further comprising an outlet valve configured to control the flow of therapeutic substance from the pumping chamber into the infusion port.

26. An implantable therapeutic substance delivery device comprising:

at least one housing, wherein the at least one housing comprises a first housing coupled to a second housing;

a therapeutic substance reservoir carried in one of the at least one housing, the therapeutic substance reservoir having a reservoir outlet;

a power source carried in one of the at least one housing;

electronics coupled to the power source;

a piston pump coupled to the electronics and coupled to the reservoir outlet, the piston pump comprising a pump cylinder in which a pump piston moves and an inlet chamber in fluid communication with a pumping chamber through a fluid path in the pump cylinder, wherein the piston pump is configured for pumping therapeutic substance from the therapeutic substance reservoir through an infusion port at a programmed rate;

an inlet valve in fluid communication with the reservoir, the inlet valve configured for controlling therapeutic substance flow from the inlet chamber into the pumping chamber; and

an anti-cavitation valve in fluid communication with the reservoir outlet and the inlet chamber, the anti-cavitation substantially preventing retrograde flow of therapeutic substance from the inlet chamber back toward the reservoir outlet.

27. The implantable therapeutic substance delivery device as in claim 26 wherein the therapeutic substance reservoir is carried in the first housing and the piston pump is carried in the second housing.

28. The implantable therapeutic substance delivery device as in claim 26 wherein the anti-cavitation valve is carried on an inlet enclosure that is in fluid communication with the inlet chamber.

29. The implantable therapeutic substance delivery device as in claim 26 wherein the anti-cavitation valve is carried in the reservoir outlet that is in fluid communication with the inlet chamber.

30. The implantable therapeutic substance delivery device as in claim 26 further comprising an outlet valve configured to control the flow of therapeutic substance from the pumping chamber into the infusion port.

31. An implantable therapeutic substance delivery device comprising:

at least one housing, wherein the at least one housing comprises a first housing coupled to a second housing;

a therapeutic substance reservoir carried in one of the at least one housing, the therapeutic substance reservoir having a reservoir outlet;

a power source carried in one of the at least one housing;

electronics coupled to the power source;

means for pumping coupled to the electronics and coupled to the reservoir outlet, the means for pumping configured to pump a therapeutic substance from the therapeutic substance reservoir through an infusion outlet at a programmed rate;

means for inlet valving configured to control the flow of therapeutic substance from the reservoir outlet into a pumping chamber; and

means for anti-cavitation valving configured to substantially prevent retrograde flow of therapeutic substance from the inlet chamber back toward the reservoir outlet.

32. The implantable therapeutic substance delivery device as in claim 31 wherein the therapeutic substance reservoir is carried in the first housing and the means for pumping is carried in the second housing.

33. The implantable therapeutic substance delivery device as in claim 31 wherein the means for anti-cavitation valving is carried on an inlet enclosure that is in fluid communication with the inlet chamber.

34. The implantable therapeutic substance delivery device as in claim 31 wherein the means for anti-cavitation valving is carried in the reservoir outlet that is in fluid communication with the inlet chamber.

35. The implantable therapeutic substance delivery device as in claim 31 further comprising an outlet valve configured to control the flow of therapeutic substance from the pumping chamber into the infusion port.

36. An implantable therapeutic substance delivery device comprising:

a housing;

a therapeutic substance reservoir carried in the housing, the therapeutic substance reservoir having a reservoir outlet;

a power source carried in the housing;

electronics coupled to the power source; and

,

a piston pump coupled to the electronics and coupled to the reservoir outlet, the piston pump comprising a pump cylinder in which a pump piston moves and an inlet chamber in fluid communication with a pumping chamber through a fluid path in the pump cylinder, wherein the piston pump is configured for pumping therapeutic substance from the therapeutic substance reservoir through an infusion port at a programmed rate;

an inlet valve in fluid communication with the reservoir, the inlet valve configured for controlling therapeutic substance flow from the inlet chamber into the pumping chamber;

an anti-cavitation valve in fluid communication with the reservoir outlet and the inlet chamber, the anti-cavitation substantially preventing retrograde flow of therapeutic substance from the inlet chamber back toward the reservoir outlet; and

an outlet valve configured to control the flow of therapeutic substance from the pumping chamber into the infusion port.

37. The implantable therapeutic substance delivery device as in claim 36 wherein the anti-cavitation valve causes a pumping chamber to fill more completely when the pump piston is retracted.

38. The implantable therapeutic substance delivery device as in claim 36 wherein the anti-cavitation valve improves piston pump efficiency by infusing substantially all the therapeutic substance that enters the inlet chamber.

39. The implantable therapeutic substance delivery device as in claim 36 wherein the anti-cavitation valve is carried on an inlet enclosure that is in fluid communication with the inlet chamber.

40. The implantable therapeutic substance delivery device as in claim 36 wherein the anti-cavitation valve is carried in the reservoir outlet that is in fluid communication with the inlet chamber.

41. An implantable therapeutic substance delivery device comprising:

at least one housing;

a therapeutic substance reservoir carried in one of the at least one housing, the therapeutic substance reservoir having a reservoir outlet;

a power source carried in one of the at least one housing;

electronics coupled to the power source;

a piston pump coupled to the electronics and coupled to the reservoir outlet, the piston pump comprising a pump cylinder in which a pump piston moves and an inlet chamber in fluid communication with a pumping chamber through a fluid path in the pump cylinder, wherein the piston pump is configured for pumping therapeutic substance from the therapeutic substance reservoir through an infusion port at a programmed rate;

an inlet valve in fluid communication with the reservoir, the inlet valve configured for controlling therapeutic substance flow from the inlet chamber into the pumping chamber;

an anti-cavitation valve in fluid communication with the reservoir outlet and the inlet chamber, the anti-cavitation substantially preventing retrograde flow of therapeutic substance from the inlet chamber back toward the reservoir outlet; and

an outlet valve configured to control the flow of therapeutic substance from the pumping chamber into the infusion port.

42. The implantable therapeutic substance delivery device as in claim 41 wherein the at least one housing comprises only one housing.

43. The implantable therapeutic substance delivery device as in claim 41 wherein the anti-cavitation valve is carried on an inlet enclosure that is in fluid communication with the inlet chamber.

44. The implantable therapeutic substance delivery device as in claim 41 wherein the anti-cavitation valve is carried in the reservoir outlet that is in fluid communication with the inlet chamber.

45. An implantable therapeutic substance delivery device comprising:

at least one housing;

a therapeutic substance reservoir carried in one of the at least one housing, the therapeutic substance reservoir having a reservoir outlet;

a power source carried in one of the at least one housing;

electronics coupled to the power source;

means for pumping coupled to the electronics and coupled to the reservoir outlet, the means for pumping configured to pump a therapeutic substance from the therapeutic substance reservoir through an infusion outlet at a programmed rate;

means for inlet valving configured to control the flow of therapeutic substance from the reservoir outlet into a pumping chamber; and

means for anti-cavitation valving configured to substantially prevent retrograde flow of therapeutic substance from the inlet chamber back toward the reservoir outlet;

an outlet valve configured to control the flow of therapeutic substance from the pumping chamber into the infusion port.

46. The implantable therapeutic substance delivery device as in claim 45 wherein the at least one housing comprises only one housing.

47. The implantable therapeutic substance delivery device as in claim 45 wherein the means for anti-cavitation valving is carried on an inlet enclosure that is in fluid communication with the inĺ

et chamber.

48. The implantable therapeutic substance delivery device as in claim 45 wherein the means for anti-cavitation valving is carried in the reservoir outlet that is in fluid communication with the inlet chamber.